Horner's Syndrome Diagnosis: A Comprehensive Guide for Clinicians

Horner syndrome, also known as oculosympathetic palsy, is a relatively uncommon clinical entity arising from the disruption of the sympathetic nerve pathway that controls various functions of the eye and face. Characterized classically by a triad of symptoms – partial ptosis (drooping eyelid), miosis (pupil constriction), and facial anhidrosis (reduced sweating) – Horner syndrome is not a disease in itself but rather a sign of an underlying medical condition. Accurate and timely Horner’s syndrome diagnosis is crucial as it can indicate a range of pathologies, from benign conditions to serious, life-threatening disorders such as tumors or carotid artery dissection. This article provides an in-depth review of Horner syndrome, focusing on its diagnosis, underlying etiologies, evaluation methodologies, and the critical role of an interprofessional approach in patient management.

Understanding the Neuroanatomy of Horner Syndrome

A thorough understanding of the sympathetic pathway to the eye is fundamental for accurate Horner’s syndrome diagnosis and localization of the lesion. This pathway is composed of three neurons in series, originating in the hypothalamus and ultimately innervating the iris dilator and superior tarsal muscles (Müller’s muscle).

First-order neurons (Central): Originating in the posterolateral hypothalamus, these neurons descend ipsilaterally through the brainstem, passing through the midbrain and pons without crossing. They terminate in the intermediolateral cell column of the spinal cord, specifically at the C8-T2 levels, also known as the ciliospinal center of Budge. Lesions affecting these neurons are termed central Horner syndrome.
Second-order neurons (Preganglionic): These neurons emerge from the spinal cord at the T1 level and enter the sympathetic chain. They ascend within the cervical sympathetic chain, synapsing in the superior cervical ganglion, typically located at the C3-C4 level. Damage along this segment results in preganglionic Horner syndrome.
Third-order neurons (Postganglionic): Postganglionic fibers from the superior cervical ganglion bifurcate. Sudomotor and vasomotor fibers follow the external carotid artery, innervating facial sweat glands and blood vessels. The remaining fibers ascend along the internal carotid artery through the carotid plexus, entering the cavernous sinus where they associate with the abducens nerve (CN VI). Finally, these fibers enter the orbit via the superior orbital fissure, joining the ophthalmic branch (V1) of the trigeminal nerve (CN V) as the long ciliary nerves, ultimately reaching the iris dilator and Müller’s muscle. Lesions distal to the superior cervical ganglion cause postganglionic Horner syndrome.

Etiology: Unraveling the Causes Behind Horner Syndrome

Horner’s syndrome diagnosis necessitates identifying the underlying cause, which can be diverse and categorized based on the anatomical location of the lesion along the sympathetic pathway. While most cases are acquired due to various systemic, local, or iatrogenic factors, congenital and hereditary forms, though rare, are also recognized.

First-Order Neuron Lesions (Central Horner Syndrome)

Disruptions in the central pathway are typically associated with conditions affecting the brainstem and spinal cord:

Cerebrovascular Accidents (CVA): Stroke affecting the brainstem can interrupt the descending sympathetic tracts.
Multiple Sclerosis (MS): Demyelinating lesions in the brainstem or spinal cord can disrupt neuronal pathways.
Arnold-Chiari Malformation: Structural defects at the base of the skull and cerebellum can compress or damage neural tissue.
Encephalitis and Meningitis: Infections causing inflammation of the brain or meninges can affect central sympathetic pathways.
Lateral Medullary Syndrome (Wallenberg Syndrome): Infarction of the lateral medulla often involves the sympathetic pathway, leading to Horner syndrome alongside other neurological deficits.
Syringomyelia: Cyst formation within the spinal cord can expand and damage surrounding neural tracts.
Intracranial Tumors: Tumors of the pituitary gland or basal skull can compress or invade the central sympathetic pathway.
Spinal Trauma: Trauma to the spinal cord above the T2-T3 level can disrupt descending sympathetic fibers.
Spinal Cord Tumors: Tumors within the spinal cord can directly damage the sympathetic pathway.

Second-Order Neuron Lesions (Preganglionic Horner Syndrome)

Lesions affecting the preganglionic neurons, traversing the thoracic region, are often linked to conditions in the neck and chest:

Pancoast Tumor: Apical lung tumors can invade the cervical sympathetic chain, commonly causing preganglionic Horner syndrome.
Cervical Rib: An extra rib in the cervical region can compress or injure the sympathetic chain.
Subclavian Artery Lesions: Aneurysms or other lesions of the subclavian artery can impinge upon the sympathetic chain.
Mediastinal Lymphadenopathy: Enlarged lymph nodes in the mediastinum, due to malignancy or infection, can compress the sympathetic pathway.
Brachial Plexus Trauma: Injuries to the brachial plexus can sometimes involve the sympathetic chain.
Neuroblastoma: In children, neuroblastoma of the paravertebral sympathetic chain is a significant cause of preganglionic Horner syndrome.
Dental Abscess: Rarely, infections in the mandibular region can affect the cervical sympathetic chain.
Iatrogenic Causes: Surgical procedures such as thyroidectomy, radical neck dissection, tonsillectomy, coronary artery bypass grafting, and carotid angiography can inadvertently damage the sympathetic chain.

Third-Order Neuron Lesions (Postganglionic Horner Syndrome)

Postganglionic lesions, affecting neurons in close proximity to the internal carotid artery and cavernous sinus, are associated with:

Carotid Cavernous Fistula: Abnormal connection between the carotid artery and cavernous sinus can compress surrounding structures.
Internal Carotid Artery Dissection or Aneurysm: These conditions can directly damage the postganglionic sympathetic fibers.
Cluster Headaches and Migraines: These headache disorders may sometimes be associated with transient Horner syndrome.
Raeder Paratrigeminal Syndrome: Characterized by unilateral facial pain, headache, and Horner syndrome, often involving the middle cranial fossa.
Herpes Zoster Infection: Infection affecting the ophthalmic branch of the trigeminal nerve can involve the adjacent sympathetic fibers.
Temporal Arteritis: Inflammation of the temporal artery and nearby vessels can affect the carotid artery and surrounding sympathetic plexus.

Epidemiology and Prevalence

Horner syndrome is considered a relatively rare condition, with an estimated incidence of approximately 1 in 6,000 individuals. It can affect individuals of any age, gender, and ethnicity. While prevalence data specific to Horner’s syndrome diagnosis are not readily available, its rarity underscores the importance of meticulous clinical evaluation and awareness among healthcare providers.

Pathophysiology: Mechanisms Underlying Horner Syndrome

The clinical manifestations of Horner syndrome arise directly from the disruption of sympathetic innervation. The severity of symptoms can vary depending on the degree and location of nerve fiber damage.

Ptosis: Partial ptosis in Horner syndrome results from denervation of the superior tarsal muscle (Müller’s muscle), which assists the levator palpebrae superioris in elevating the upper eyelid. Unlike the complete ptosis seen in oculomotor nerve (CN III) palsy, Horner’s ptosis is milder because the levator palpebrae superioris, innervated by CN III, remains functional. A subtle elevation of the lower eyelid may also be observed due to denervation of the inferior tarsal muscle, analogous to Müller’s muscle in the upper lid.
Miosis: The sympathetic nervous system mediates pupillary dilation (mydriasis). Disruption of this pathway leads to unopposed parasympathetic activity, resulting in pupil constriction (miosis). Importantly, pupillary light and accommodation reflexes remain intact as these are primarily mediated by the parasympathetic nervous system. The hallmark of Horner’s miosis is dilation lag – the affected pupil dilates slower than the normal pupil in dim light.
Anhidrosis: Ipsilateral facial anhidrosis, or reduced sweating, depends on the level of sympathetic disruption. First-order neuron lesions may cause anhidrosis affecting the ipsilateral side of the body. Second-order lesions typically involve anhidrosis of the ipsilateral face. Postganglionic third-order lesions, after the branching of sudomotor fibers, may result in very limited anhidrosis, often restricted to the area adjacent to the ipsilateral eyebrow.
Iris Heterochromia: Congenital Horner syndrome, particularly when occurring before the age of 2 years, can present with iris heterochromia – a difference in iris color between the eyes. This occurs due to a deficiency of pigment in the iris on the affected side, reflecting disrupted sympathetic influence on melanocytes during iris development.

History and Physical Examination: Cornerstones of Horner’s Syndrome Diagnosis

A detailed history and thorough physical examination are paramount in the Horner’s syndrome diagnosis process, particularly for lesion localization and identifying potential underlying causes. Key aspects of the history include:

Associated Neurological Symptoms: Balance problems, hearing loss, sensory deficits, or swallowing difficulties may suggest a central lesion affecting first-order neurons.
Trauma or Surgery History: Prior trauma or surgical interventions involving the head, face, neck, shoulder, or back may point to second-order neuron involvement.
Medication History: A comprehensive medication review is crucial to rule out the use of miotic or mydriatic agents that can mimic or mask Horner syndrome.
Headache and Pain Characteristics: Headache, double vision, facial numbness, or pain can indicate third-order neuron involvement, potentially suggesting conditions like carotid dissection or cluster headaches.
Anhidrosis Assessment: Determining the presence and location of anhidrosis is vital for lesion localization.
Headache History: Detailed characterization of headaches, including onset, frequency, intensity, and associated symptoms, is important.
Symptom Chronicity and Progression: Longstanding, stable symptoms are more suggestive of benign etiologies, while recent onset or progressive symptoms, especially accompanied by weight loss, hemoptysis, fever, or lymphadenopathy, raise suspicion for more serious underlying conditions like malignancy.
Facial Flushing: Facial flushing may be indicative of a preganglionic lesion.
Facial or Orbital Pain: Pain in the face or orbit, combined with miosis and ptosis, can suggest Raeder paratrigeminal syndrome.
Skin Lesions or Herpes Zoster History: History of skin lesions or prior herpes zoster infection can suggest postganglionic involvement.
Pain Severity and Location: Detailed pain assessment helps in differentiating various etiologies.

The ocular examination is crucial for confirming Horner’s syndrome diagnosis and should include:

Pupillary Light and Accommodation Reflexes: Assess pupillary reactions to light and accommodation to ensure parasympathetic function is intact.
Pupillary Diameter Measurement: Measure pupillary diameters in both bright and dim light to quantify anisocoria (unequal pupil size) and dilation lag. Anisocoria is typically more pronounced in darkness.
Eyelid Examination: Evaluate the upper eyelid for ptosis and fatigability. Assess for subtle lower eyelid elevation.
Extraocular Movements: Check for any limitations or abnormalities in eye movements to rule out other cranial nerve palsies.
Visual Acuity and Fields: Assess vision, including color vision and visual fields, to evaluate for associated visual pathway involvement.
Slit-Lamp Examination: Perform a slit-lamp examination to assess anterior segment structures and rule out other ocular pathologies.
Nystagmus Evaluation: Examine for nystagmus, which might suggest central nervous system involvement.
Ciliospinal Reflex: Assess for the ciliospinal reflex (pupillary dilation upon painful stimuli to the neck); its absence may support Horner’s syndrome diagnosis.

Additional signs that may be observed during physical examination include apparent enophthalmos (sunken eye), contralateral eyelid retraction, conjunctival injection, and potentially transient or no change in intraocular pressure. A comprehensive systemic examination, focusing on neurological, pulmonary, and cardiovascular systems, is essential to identify potential underlying causes and guide further investigations.

Diagnostic Evaluation: Confirming Horner Syndrome and Identifying the Lesion

Horner’s syndrome diagnosis relies on a combination of clinical assessment and diagnostic testing. Pharmacological testing plays a pivotal role in confirming the diagnosis and often aids in lesion localization. Imaging studies are crucial for identifying the underlying etiology.

Laboratory Investigations

While laboratory tests are not primary for Horner’s syndrome diagnosis, they may be indicated to investigate suspected underlying conditions:

Complete Blood Count (CBC), Erythrocyte Sedimentation Rate (ESR), and Serum Chemistry Panel: These initial blood tests can screen for systemic inflammatory or infectious processes.
Urine or Blood Cultures: If infection is suspected as an underlying cause, cultures may be warranted.
Neurosyphilis, HIV, Thyroid Function, Vitamin B-12, and Folate Testing: These tests may be considered based on clinical suspicion and risk factors.
Urine Catecholamine Metabolites: In pediatric cases, urine testing for vanillylmandelic acid (VMA) and homovanillic acid (HVA) is crucial to screen for neuroblastoma.
Purified Protein Derivative (PPD) Test: Tuberculosis should be considered in the differential diagnosis, particularly in preganglionic Horner syndrome, and PPD testing may be indicated.

Imaging Modalities

Imaging is essential for identifying the underlying cause and location of the lesion in Horner’s syndrome diagnosis:

Chest X-ray and Computed Tomography (CT): In adults, especially smokers or those with respiratory symptoms, chest imaging is critical to rule out Pancoast tumors or other pulmonary malignancies. CT is more sensitive than X-ray for detecting apical lung lesions and mediastinal masses.
Head CT and Magnetic Resonance Imaging (MRI): In cases suggestive of central Horner syndrome or stroke, head CT and MRI are indicated to evaluate for brainstem lesions, infarcts, tumors, or demyelinating plaques.
Cervical and Thoracic Spine MRI: MRI of the cervical and thoracic spine can be helpful in identifying spinal cord tumors, syringomyelia, or trauma-related lesions.
Carotid Artery Imaging (MRI or CT Angiography): In painful Horner syndrome, particularly with headache or neck pain, imaging of the carotid arteries (MRI or CT angiography) is crucial to rule out carotid artery dissection. MRI is generally preferred for its higher sensitivity in detecting dissection.

Pharmacological Testing: Confirming and Localizing the Lesion

Pharmacological testing is a valuable tool in Horner’s syndrome diagnosis and can often help differentiate between preganglionic and postganglionic lesions. Several agents are used, each with its own mechanism and utility:

Topical Cocaine Test: Cocaine blocks the reuptake of norepinephrine at the synapse, enhancing sympathetic activity. In Horner syndrome, the denervated pupil has reduced norepinephrine release. Instillation of cocaine eye drops (2-10%) in both eyes will result in poor dilation of the affected pupil compared to the normal eye. Anisocoria of 0.8 mm or greater after 30-45 minutes is considered suggestive of Horner syndrome. However, cocaine testing does not localize the lesion and has become less favored due to availability and regulatory issues.
Topical Apraclonidine Test: Apraclonidine is a weak alpha1-adrenergic agonist and a stronger alpha2-adrenergic agonist. In Horner syndrome, there is upregulation (supersensitivity) of alpha1-adrenergic receptors in the iris dilator muscle. Instillation of apraclonidine (0.5-1%) in both eyes will cause exaggerated dilation of the affected pupil due to alpha1-receptor supersensitivity, while the normal pupil shows minimal response or even constriction due to alpha2-agonist effects. Reversal of anisocoria (affected pupil dilates more than the normal pupil) is a strong indicator of Horner syndrome. The apraclonidine test is often considered the preferred first-line pharmacological test due to its higher sensitivity and practicality compared to cocaine. It, however, does not localize the lesion and may yield false-negative results in acute Horner syndrome.
Topical Hydroxyamphetamine Test: Hydroxyamphetamine (Paredrine) stimulates the release of stored norepinephrine from postganglionic sympathetic nerve terminals. This test is useful for differentiating between preganglionic (first and second-order neuron) and postganglionic (third-order neuron) lesions. Instillation of 1% hydroxyamphetamine solution in both eyes will result in dilation of the pupil if postganglionic neurons are intact (first and second-order lesions). In third-order neuron lesions, where postganglionic fibers are damaged, the affected pupil will dilate poorly or not at all compared to the normal eye. A significant difference in dilation (≥1 mm) suggests a postganglionic lesion. This test cannot be performed on the same day as the cocaine test and may produce false-negative results.

Other pharmacological agents like phenylephrine and adrenaline have been proposed but are less clinically relevant due to limitations in corneal penetration or variable sensitivity.

Treatment and Management Strategies

Treatment for Horner syndrome is directed at managing the underlying cause. Therefore, accurate Horner’s syndrome diagnosis and etiological identification are paramount. Management strategies are highly dependent on the diagnosed underlying condition and may involve:

Medical Management: For conditions like cluster headaches, migraines, or infections, medical treatment targeting the primary disorder is indicated.
Surgical Intervention: In cases of structural lesions like tumors, aneurysms, or carotid artery dissection, surgical intervention may be necessary. Neurosurgical or vascular surgical consultation is crucial in these scenarios.
Observation and Monitoring: For idiopathic Horner syndrome, or when a benign cause is identified and treated, observation and monitoring may be appropriate.

Prompt referral to specialists, including neurologists, neuro-ophthalmologists, pulmonologists, oncologists, or vascular surgeons, is essential based on the suspected underlying etiology.

Differential Diagnosis: Distinguishing Horner Syndrome from Mimicking Conditions

Horner’s syndrome diagnosis requires differentiation from other conditions that can present with similar signs, such as:

Holmes-Adie Syndrome: Characterized by a tonically dilated pupil with light-near dissociation (poor light reaction, better reaction to accommodation) and diminished deep tendon reflexes.
Argyll Robertson Pupil: Seen in neurosyphilis, these pupils are small, irregular, and also exhibit light-near dissociation.
Third Nerve Palsy (Partial): Can cause ptosis and mydriasis (pupil dilation), but typically involves other signs like diplopia and limitations in eye movements not seen in Horner syndrome.
Optic Neuritis: Inflammation of the optic nerve, presenting with vision loss, pain with eye movements, and potentially afferent pupillary defect, but not typically Horner’s triad.
Physiological Anisocoria: Normal variation in pupil size, usually less than 1 mm difference and without ptosis or anhidrosis.

Careful clinical examination and pharmacological testing help distinguish Horner syndrome from these mimicking conditions.

Prognosis and Long-Term Outlook

The prognosis for Horner syndrome depends entirely on the underlying cause. Idiopathic Horner syndrome, in many cases, has a benign long-term prognosis. Studies suggest that many patients with idiopathic Horner syndrome experience spontaneous improvement in anisocoria and ptosis over time. However, it is essential to recognize that Horner syndrome itself is a sign, and the prognosis is ultimately determined by the treatability and course of the underlying pathology.

Potential Complications

Complications associated with Horner syndrome are primarily related to the underlying cause. For instance, Horner syndrome secondary to malignancy can be associated with systemic spread and complications of cancer. Horner syndrome due to carotid artery dissection can lead to stroke or transient ischemic attacks. Eye-related complications directly from Horner syndrome are rare, but patients may experience mild dryness or gritty sensation due to reduced tear production, which can be managed with artificial tears.

Interprofessional Consultations and Team-Based Care

Effective management of Horner’s syndrome diagnosis and its underlying causes necessitates a collaborative, interprofessional healthcare team. Depending on the clinical presentation and suspected etiology, consultations may be required with specialists in:

Neurology and Neuro-ophthalmology: For central lesions, neurological conditions, and specialized ophthalmic assessment.
Pulmonology and Oncology: For suspected lung malignancies like Pancoast tumor.
Neurosurgery and Vascular Surgery: For structural lesions, aneurysms, or carotid artery dissection.
Interventional Radiology: For diagnostic angiography or potential interventional procedures.

Effective communication and coordinated care among team members are crucial to ensure timely and accurate Horner’s syndrome diagnosis, appropriate management of the underlying cause, and optimal patient outcomes.

Patient Education and Deterrence Strategies

Patient education is vital, especially for individuals diagnosed with Horner syndrome. Patients and their families should be informed about:

Nature of Horner Syndrome: Explaining that it is a sign of an underlying issue, not a disease itself.
Potential Underlying Causes: Discussing possible etiologies, ranging from benign to serious conditions, based on the clinical context.
Importance of Further Investigations: Emphasizing the need for diagnostic testing to identify the underlying cause.
Symptom Management: Addressing potential symptoms like dry eye with artificial tears or ointments.
Prognosis and Follow-up: Providing realistic expectations based on the identified cause and outlining the plan for follow-up and monitoring.
Congenital Horner Syndrome in Infants: Educating parents about management options and long-term follow-up for congenital cases.

While Horner syndrome itself cannot be prevented, awareness of risk factors for underlying conditions, such as smoking cessation to reduce lung cancer risk and prompt management of neck trauma, may indirectly reduce the occurrence of Horner syndrome secondary to preventable causes.

Enhancing Healthcare Team Outcomes

Optimal outcomes in Horner’s syndrome diagnosis and management are achieved through a well-coordinated interprofessional team approach. This includes:

Early Recognition: Clinicians across specialties should be vigilant in recognizing the signs of Horner syndrome.
Systematic Evaluation: Adhering to a structured diagnostic approach involving history, physical examination, pharmacological testing, and appropriate imaging.
Collaborative Management: Facilitating seamless communication and consultation among specialists to ensure comprehensive and timely care.
Patient-Centered Approach: Providing patient education, addressing concerns, and involving patients in decision-making.

By fostering a collaborative and knowledgeable healthcare environment, clinicians can enhance the quality of care and improve outcomes for patients presenting with Horner syndrome.

Review Questions

(Note: Review questions from the original article are assumed to be available and can be included here for educational purposes.)

References

(Include the same references as in the original article, ensuring proper formatting.)

van der Wiel HL. Johann Friedrich Horner (1831-1886). J Neurol. 2002 May;249(5):636-7. [PubMed: 12021960]
Thompson HS. Johann Friedrich Horner (1831-1886). Am J Ophthalmol. 1986 Dec 15;102(6):792-5. [PubMed: 3538884]
Johann Friedrich Horner, (1831-1886) “a form of ptosis”. JAMA. 1969 Jun 09;208(10):1899-900. [PubMed: 4890333]
Mitchell SW, Morehouse GR, Keen WW. Gunshot wounds and other injuries of nerves. 1864. Clin Orthop Relat Res. 2007 May;458:35-9. [PubMed: 17473596]
DURHAM DG. Congenital hereditary Horner’s syndrome. AMA Arch Ophthalmol. 1958 Nov;60(5):939-40. [PubMed: 13582337]
Amonoo-Kuofi HS. Horner’s syndrome revisited: with an update of the central pathway. Clin Anat. 1999;12(5):345-61. [PubMed: 10462732]
Lee JH, Lee HK, Lee DH, Choi CG, Kim SJ, Suh DC. Neuroimaging strategies for three types of Horner syndrome with emphasis on anatomic location. AJR Am J Roentgenol. 2007 Jan;188(1):W74-81. [PubMed: 17179330]
Biousse V, Touboul PJ, D’Anglejan-Chatillon J, Lévy C, Schaison M, Bousser MG. Ophthalmologic manifestations of internal carotid artery dissection. Am J Ophthalmol. 1998 Oct;126(4):565-77. [PubMed: 9780102]
Reede DL, Garcon E, Smoker WR, Kardon R. Horner’s syndrome: clinical and radiographic evaluation. Neuroimaging Clin N Am. 2008 May;18(2):369-85, xi. [PubMed: 18466837]
Lyrer PA, Brandt T, Metso TM, Metso AJ, Kloss M, Debette S, Leys D, Caso V, Pezzini A, Bonati LH, Thijs V, Bersano A, Touzé E, Gensicke H, Martin JJ, Lichy C, Tatlisumak T, Engelter ST, Grond-Ginsbach C., Cervical Artery Dissection and Ischemic Stroke Patients (CADISP) Study Group. Clinical import of Horner syndrome in internal carotid and vertebral artery dissection. Neurology. 2014 May 06;82(18):1653-9. [PubMed: 24727317]
Jadon A. Horner’s syndrome and weakness of upper limb after epidural anaesthesia for caesarean section. Indian J Anaesth. 2014 Jul;58(4):464-6. [PMC free article: PMC4155296] [PubMed: 25197119]
Ying X, Dandan G, Bin C. Postoperative Horner’s syndrome after video-assisted thyroidectomy: a report of two cases. World J Surg Oncol. 2013 Dec 30;11:315. [PMC free article: PMC4029459] [PubMed: 24378178]
Foss-Skiftesvik J, Hougaard MG, Larsen VA, Hansen K. Clinical Reasoning: Partial Horner syndrome and upper right limb symptoms following chiropractic manipulation. Neurology. 2015 May 26;84(21):e175-80. [PubMed: 26009566]
Sandoval MA, Cabungcal AC. Horner syndrome after radical neck surgery for anaplastic thyroid carcinoma. BMJ Case Rep. 2015 Apr 09;2015 [PMC free article: PMC4401968] [PubMed: 25858945]
Smith SJ, Diehl N, Leavitt JA, Mohney BG. Incidence of pediatric Horner syndrome and the risk of neuroblastoma: a population-based study. Arch Ophthalmol. 2010 Mar;128(3):324-9. [PMC free article: PMC3743544] [PubMed: 20212203]
Kucur C, Ozbay I, Oghan F, Yildirim N, Zeybek Sivas Z, Canbaz Kabay S. A Rare Complication of Radiofrequency Tonsil Ablation: Horner Syndrome. Case Rep Otolaryngol. 2015;2015:570520. [PMC free article: PMC4439494] [PubMed: 26064747]
Allen AY, Meyer DR. Neck procedures resulting in Horner syndrome. Ophthalmic Plast Reconstr Surg. 2009 Jan-Feb;25(1):16-8. [PubMed: 19273916]
Pirouzian A, Holz HA, Ip KC, Sudesh R. Acquired infantile Horner syndrome and spontaneous internal carotid artery dissection: a case report and review of literature. J AAPOS. 2010 Apr;14(2):172-4. [PubMed: 20451860]
Guglielmi V, Visser J, Arnold M, Sarikaya H, van den Berg R, Nederkoorn PJ, Leys D, Calvet D, Kloss M, Pezzini A, Tatlisumak T, Schilling S, Debette S, Coutinho JM. Triple and quadruple cervical artery dissections: a systematic review of individual patient data. J Neurol. 2019 Jun;266(6):1383-1388. [PMC free article: PMC6517349] [PubMed: 30904955]
Kong YX, Wright G, Pesudovs K, O’Day J, Wainer Z, Weisinger HS. Horner syndrome. Clin Exp Optom. 2007 Sep;90(5):336-44. [PubMed: 17697179]
Walker L, French S. Horner’s Syndrome: A Case Report and Review of the Pathophysiology and Clinical Features. West Indian Med J. 2014 Jun;63(3):278-80. [PMC free article: PMC4663911] [PubMed: 25314289]
Ofri A, Malka V, Lodh S. Horner’s syndrome in traumatic first rib fracture without carotid injury; review of anatomy and pathophysiology. Trauma Case Rep. 2017 Apr;8:1-4. [PMC free article: PMC5883210] [PubMed: 29644305]
Morrison DA, Bibby K, Woodruff G. The “harlequin” sign and congenital Horner’s syndrome. J Neurol Neurosurg Psychiatry. 1997 Jun;62(6):626-8. [PMC free article: PMC1074149] [PubMed: 9219751]
Cho TT, Da Costa JL. Raeder’s paratrigeminal syndrome. Singapore Med J. 1968 Jun;9(2):92-7. [PubMed: 4300458]
González-Aguado R, Morales-Angulo C, Obeso-Agüera S, Longarela-Herrero Y, García-Zornoza R, Acle Cervera L. Horner’s syndrome after neck surgery. Acta Otorrinolaringol Esp. 2012 Jul-Aug;63(4):299-302. [PubMed: 22502736]
Almog Y, Gepstein R, Kesler A. Diagnostic value of imaging in horner syndrome in adults. J Neuroophthalmol. 2010 Mar;30(1):7-11. [PubMed: 20182199]
Smit DP. Pharmacologic testing in Horner’s syndrome – a new paradigm. S Afr Med J. 2010 Nov 09;100(11):738-40. [PubMed: 21081027]
Mughal M, Longmuir R. Current pharmacologic testing for Horner syndrome. Curr Neurol Neurosci Rep. 2009 Sep;9(5):384-9. [PubMed: 19664368]
Bremner F. Apraclonidine Is Better Than Cocaine for Detection of Horner Syndrome. Front Neurol. 2019;10:55. [PMC free article: PMC6371044] [PubMed: 30804875]
Koc F, Kavuncu S, Kansu T, Acaroglu G, Firat E. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. Br J Ophthalmol. 2005 Nov;89(11):1442-4. [PMC free article: PMC1772929] [PubMed: 16234449]
Bellégo C, Borruat FX, Kawasaki A. Long-term prognosis of patients with idiopathic Horner syndrome. J Neurol. 2022 May;269(5):2781-2783. [PubMed: 34839389]

Disclosures:

(Include the same disclosures as in the original article.)

Disclosure: Zalan Khan declares no relevant financial relationships with ineligible companies.

Disclosure: Pradeep Bollu declares no relevant financial relationships with ineligible companies.

Horner’s Syndrome Diagnosis: A Comprehensive Guide for Clinicians